Skip to main content
HOSPITALScience City Rd+91 97234 31544
AEC CLINICNaranpura+91 70460 02566
WhatsApp Hospital 11:00 AM – 8:00 PM | Clinic 8:30 AM – 10:30 AM

Balaji Horizon Women's Hospital

βœ“Last clinically reviewed by Dr. Priyadatt Patel on 8 June 2026

Adenomyosis Treatment in Ahmedabad β€” Balaji Horizon Women’s Hospital

Adenomyosis is a chronic condition in which the inner lining of the uterus (endometrium) grows into the muscular wall of the uterus (myometrium), causing it to enlarge, inflame, and bleed with each menstrual cycle. It is one of the most underdiagnosed causes of heavy periods, severe pelvic pain, and unexplained infertility β€” often dismissed for years as “just bad periods.” At Balaji Horizon Women’s Hospital, Ahmedabad, we offer a comprehensive, evidence-based adenomyosis programme that covers accurate diagnosis, individualised medical management, fertility-preserving surgical options, and IVF planning for women with adenomyosis-related infertility.


ISO9001:2015Bureau Veritas
CEARegistered ClinicPermanent registration
ARTICMR Level 2 LabNational ART registry
ESHGuideline-alignedESHRE / ASRM
ISUISUOG IDEAImaging protocol

What Is Adenomyosis? Understanding the Condition

The uterus has two main layers: the endometrium (inner lining, shed each month during menstruation) and the myometrium (thick outer muscular wall). In adenomyosis, endometrial glands and stroma are found embedded within the myometrium β€” where they do not belong. These ectopic endometrial islands respond to the monthly hormonal cycle: they proliferate, thicken, and bleed β€” but the blood has nowhere to go. The result is uterine wall oedema, inflammation, smooth muscle hypertrophy, and eventual diffuse or focal uterine enlargement.

Adenomyosis is classified as:

  • Diffuse adenomyosis β€” endometrial tissue spread throughout the entire myometrium, causing generalised uterine enlargement (“bulky uterus” on ultrasound)
  • Focal adenomyosis (adenomyoma) β€” a localised collection of adenomyotic tissue forming a poorly defined mass within the myometrium, similar in appearance to a fibroid but without a capsule
  • Superficial adenomyosis β€” limited to the inner one-third of the myometrium; associated with infertility and implantation failure
  • Deep adenomyosis β€” penetrating into the outer two-thirds or full thickness of the myometrium; associated with more severe symptoms and greater impact on uterine contractility

Adenomyosis and endometriosis frequently coexist β€” estimated in 20–50% of patients with endometriosis. This combination significantly complicates both pain management and fertility planning. See: Endometriosis management at Balaji Horizon β†’


Symptoms of Adenomyosis

Heavy Menstrual Bleeding (Menorrhagia)

The enlarged, congested uterine wall leads to heavier and more prolonged menstrual bleeding. Many women with adenomyosis pass clots, require frequent pad or tampon changes, and develop iron-deficiency anaemia from chronic blood loss. Heavy periods are often the presenting complaint, particularly in women in their late 30s and 40s β€” and frequently normalised (“it runs in the family”), delaying diagnosis by years.

Severe Dysmenorrhoea (Period Pain)

Adenomyosis causes cramping pain that often begins before menstruation and worsens during it β€” typically diffuse, deep, and central. Many women describe it as a heavy, bearing-down pelvic pain radiating to the lower back and thighs. Standard NSAIDs provide partial relief at best. The pain is driven by prostaglandin release from the inflamed myometrium and impaired uterine contractility.

Chronic Pelvic Pain and Dyspareunia

Unlike pure endometriosis (which is often cyclical), adenomyosis can cause background chronic pelvic pain that worsens around menstruation. Deep dyspareunia (pain during intercourse) can also occur, particularly in women with posterior adenomyosis.

Bulky Uterus and Pelvic Pressure

Adenomyosis causes the uterus to enlarge β€” sometimes to the size of a 12–14-week pregnancy in severe diffuse disease β€” causing a sensation of fullness or pressure in the lower abdomen and urinary frequency from bladder compression.

Infertility and Recurrent Pregnancy Loss

Adenomyosis impairs fertility through altered uterine contractility, junctional zone hyperplasia, inflammatory cytokines within the uterine cavity, and impaired endometrial receptivity. Studies suggest adenomyosis is associated with a 2–4-fold increase in implantation failure after IVF β€” an underappreciated cause of recurrent IVF failure. See: IVF Centre Ahmedabad β€” integrated fertility care β†’


Diagnosing Adenomyosis

Transvaginal Ultrasound (TVUS)

First-line diagnostic tool. Ultrasound features include: uterine enlargement with globular configuration, asymmetric myometrial thickening, heterogeneous myometrial echotexture with echogenic islands or linear striations, myometrial cysts (anechoic lacunae), poorly defined endometrial-myometrial junction, and increased myometrial vascularity. Accuracy depends critically on operator experience. At Balaji Horizon, gynaecological ultrasound is performed by Dr. Priyadatt Patel β€” an advanced gynaecological ultrasonographer with specific training in endometriosis and adenomyosis ultrasound mapping.

MRI (Magnetic Resonance Imaging)

The gold standard when ultrasound findings are equivocal, when differentiating adenomyosis from fibroids, or when pre-operative surgical planning requires detailed mapping. Key MRI findings: junctional zone thickness above 12 mm (most reliable criterion), high-signal foci within low-signal myometrium on T2-weighted imaging, and uterine asymmetry. MRI is particularly useful for distinguishing adenomyoma from fibroid β€” a distinction with major surgical implications.

Histology (Definitive Confirmation)

The definitive diagnosis remains histological β€” identification of endometrial glands and stroma within the myometrium. Obtained after hysterectomy or, in fertility-preserving surgery, from excised adenomyoma tissue during adenomyomectomy. Endometrial biopsy alone cannot diagnose adenomyosis.


Adenomyosis Treatment Options β€” Medical and Surgical

Treatment options at a glance

OptionBest forNote
LNG-IUS (Mirena)Heavy bleeding with painFirst-line, uterus-sparing
Progestins / combined pillSymptom controlContinuous use
GnRH analoguesShort-term or pre-opWith add-back therapy
Uterine artery embolisationSelected, family completeSpecialist procedure
Focal adenomyomectomyFocal disease, fertility wishLimited, specialised
HysterectomyDefinitive, family completeCurative

Medical Management β€” Hormonal Suppression

Adenomyosis is oestrogen-dependent. Reducing oestrogen exposure suppresses ectopic endometrial activity, reducing bleeding, pain, and uterine volume. Options include:

  • Levonorgestrel IUS (Mirena) β€” most effective for heavy bleeding and pain; local progestogen release reduces endometrial proliferation significantly. Most effective in mild-moderate adenomyosis.
  • Dienogest (Visanne) β€” oral progestogen with specific anti-endometriotic properties; effective for pain reduction and some volume reduction. Can be used long-term. Preferred in younger women with pain as the primary complaint.
  • Combined oral contraceptive pill (COCP) β€” cyclical or continuous use reduces dysmenorrhoea and lightens periods; generally less effective than LNG-IUS or dienogest but useful as first-line in younger patients.
  • GnRH agonists (leuprolide, triptorelin) β€” medical menopause; very effective at suppressing adenomyosis and reducing uterine volume (up to 40%); used 3–6 months pre-operatively or pre-IVF. Not suitable long-term without add-back therapy.
  • Progestogen-only pill or injectable (Depo-Provera) β€” second-line; variable response.

Medical management does not cure adenomyosis β€” it suppresses activity while the medication is used. Symptoms typically return after stopping. This is especially relevant for women who wish to conceive: hormonal suppression must be discontinued before attempting pregnancy.

Surgical Management β€” Fertility-Preserving Options

Adenomyomectomy β€” surgical excision of a focal adenomyoma β€” is feasible laparoscopically in selected cases. Unlike fibroid myomectomy, adenomyomectomy is technically more challenging because adenomyosis does not have a capsule and blends into the surrounding myometrium. The goal is excision of the bulk of adenomyotic tissue while preserving as much normal myometrium as possible. Appropriate for: women with focal adenomyoma causing significant symptoms, women who wish to preserve the uterus, or as part of an IVF preparation plan for recurrent implantation failure.

For diffuse adenomyosis, adenomyomectomy is more controversial β€” “cytoreduction” (reducing the adenomyotic burden) is sometimes performed, but evidence for fertility outcomes after surgical cytoreduction of diffuse adenomyosis remains limited. See: Advanced laparoscopic surgery at Balaji Horizon β†’

Laparoscopic Hysterectomy β€” Definitive Treatment

For women who have completed their family with significant adenomyosis-related symptoms unresponsive to medical management, laparoscopic hysterectomy is the definitive and permanent treatment. We always confirm explicitly that the patient has fully considered this before proceeding.

Adenomyosis and IVF β€” When Is IVF the Right Path?

For women with adenomyosis-related infertility, key considerations for IVF planning include:

  • Pre-IVF GnRH agonist downregulation for 3–6 months is recommended in women with severe adenomyosis β€” this reduces uterine volume, normalises the junctional zone, and is associated with improved implantation rates in several observational studies and meta-analyses.
  • Frozen embryo transfer (FET) is generally preferred over fresh transfer in adenomyosis β€” the artificially prepared endometrium in a freeze-all cycle may be more receptive than a stimulated endometrium in the existing adenomyotic uterine environment.
  • Adenomyomectomy before IVF may be considered for focal disease distorting the cavity or causing recurrent implantation failure β€” but RCT evidence for benefit remains limited, and uterine scar risk must be weighed carefully.
  • Recurrent IVF failure with a bulky adenomyotic uterus should prompt a structured review including ERA (endometrial receptivity array) biopsy and targeted downregulation before the next transfer.

The Adenomyosis–Endometriosis Overlap

A significant proportion of women with endometriosis also have adenomyosis. When both conditions coexist, symptom burden is typically higher, fertility outcomes more complex, and management requires coordinated planning. At Balaji Horizon, both conditions are assessed together β€” with ultrasound mapping for endometriosis and adenomyosis in the same sitting, and a unified management plan that addresses both. Full endometriosis management β†’


The guidelines we follow

Aligned with current international evidence, not habit.

Frequently Asked Questions β€” Adenomyosis

Is adenomyosis the same as endometriosis?

They are related but distinct. In endometriosis, tissue grows outside the uterus. In adenomyosis, it grows into the uterine muscle wall. Both are oestrogen-dependent, both cause pain and fertility problems, and both frequently coexist. Key clinical difference: adenomyosis causes primarily heavy bleeding and a bulky uterus; endometriosis presents more with pelvic masses, adhesions, and anatomical distortion.

Can adenomyosis be cured without hysterectomy?

Not completely. However, excellent symptomatic control and fertility outcomes are achievable without hysterectomy using hormonal suppression, focal adenomyomectomy for discrete disease, and IVF planning with pre-IVF GnRH agonist downregulation. The goal is disease control sufficient to achieve acceptable quality of life and reproductive outcomes β€” not anatomical cure.

Can I get pregnant with adenomyosis?

Yes β€” many women with adenomyosis conceive naturally or with IVF. GnRH agonist downregulation for 3–6 months before IVF improves implantation and pregnancy rates in women with significant adenomyosis. Natural conception is possible in mild disease. Management depends on severity, symptom burden, age, ovarian reserve, and fertility timeline.

What does a “bulky uterus” mean on an ultrasound report?

“Bulky uterus” indicates the uterus is larger than normal. The most common cause in women with heavy periods and pain is adenomyosis. A bulky uterus on ultrasound requires dedicated assessment β€” including myometrial texture, junctional zone measurement, and myometrial vascularity. A normal-sized uterus does not exclude adenomyosis β€” superficial or early disease may be present without significant volume increase.

How is adenomyosis different from fibroids on ultrasound?

Fibroids are discrete, well-circumscribed masses with a pseudocapsule β€” clearly delineated on ultrasound, often with posterior acoustic shadowing. Adenomyosis is ill-defined, blends into the myometrium, and is characterised by heterogeneous, asymmetric myometrial texture, myometrial cysts, and poorly defined endometrial-myometrial junction. MRI is the most reliable way to distinguish focal adenomyoma from fibroid in cases of uncertainty.

Which doctor should I see for adenomyosis in Ahmedabad?

Adenomyosis is best managed by a gynaecologist with expertise in advanced gynaecological ultrasound, endometriosis, and reproductive medicine. Dr. Priyadatt Patel at Balaji Horizon Women’s Hospital, Science City Road, Ahmedabad β€” contact: +91 97234 31544.


Are there newer uterus-sparing techniques for adenomyosis?

Emerging options include radiofrequency or microwave ablation of focal adenomyosis and high-intensity focused ultrasound (HIFU). They may help selected women — particularly with focal disease — but the evidence base is still developing, the effect on future fertility is not fully established, and they are not suitable for everyone. We counsel on them honestly, case by case.

Related Services

Adenomyosis Consultation β€” Balaji Horizon, Ahmedabad

If you have been told you have a “bulky uterus,” have heavy periods with severe pain, or have struggled with infertility or repeated IVF failure β€” bring your ultrasound reports and investigation results. We will review everything carefully and present a clear, evidence-based plan.

Hospital: Satyamev Eminence, Science City Road, Ahmedabad 380060 Β· +91 97234 31544
Clinic: 132 Ft Ring Road, Naranpura, Ahmedabad 380013 Β· +91 70460 02566

Dr Priyadatt Patel, endometriosis and advanced laparoscopic surgeon, Ahmedabad
Dr Priyadatt Patel
Endometriosis & Advanced Laparoscopic Surgeon

Dr Patel leads endometriosis diagnosis and surgery at Balaji Horizon with an evidence-based, ovarian-sparing philosophy aligned to ESHRE and ESGE — integrating pain, fertility and long-term disease control into a single plan, rather than treating the disease in isolation.

Discuss your endometriosis care with a specialist

Imaging-led diagnosis, medical-first management, and precise surgery only when it is the right step — planned around your pain and fertility goals.

Book a consultation

Adenomyosis and fertility: what IVF outcome data actually shows

If you are planning a pregnancy or IVF, the honest question is not β€œdoes adenomyosis cause infertility?” β€” many women with adenomyosis conceive β€” but β€œdoes it change the odds, and can we plan around it?” The current evidence gives a measured answer: adenomyosis is associated with a modestly lower chance of clinical pregnancy and live birth and a higher early-miscarriage risk in IVF β€” but the effect is not uniform. It is seen mainly with diffuse, symptomatic disease, and an incidental finding on a scan in a woman with no symptoms does not carry the same prognosis.

Pooled IVF outcomes β€” what the meta-analyses report

Outcome with adenomyosis vs withoutPooled effect (OR/RR, 95% CI)Source (meta-analysis)
Clinical pregnancyRR 0.72 (0.55–0.95) β€” ~28% lowerVercellini et al., 2014
Live birthOR 0.59 (0.37–0.92)Cozzolino et al., 2022
Live birth (ultrasound-diagnosed)OR 0.66 (0.53–0.82)Wang et al., 2023
MiscarriageOR ~1.8–2.1 (higher) β€” e.g. 2.11 (1.33–3.33)Cozzolino 2022; Vercellini 2014; Wang 2023
Adenomyosis and endometriosis togetherLive birth OR 0.44 (0.26–0.75) vs endometriosis aloneWang et al., 2023
Pooled IVF outcomes with adenomyosis (illustrative) 1.0 (no effect) ← lower higher → Live birth OR 0.59 Clinical pregnancy RR 0.72 Miscarriage OR 2.11
Illustrative only. Markers show pooled point estimates with 95% confidence-interval whiskers from published meta-analyses; certainty of evidence is graded low to very low. These are population averages β€” not a personal prognosis.
How to read these numbers honestly. The figures are averages pooled across heterogeneous studies, and the certainty of the evidence is rated low to very low. Three things matter more than the single number: (1) asymptomatic, incidental adenomyosis seen on a routine scan does not appear to carry the same penalty as diffuse, symptomatic disease; (2) concurrent endometriosis compounds the effect; and (3) the prognosis is something we plan around, not a verdict. A number on a meta-analysis is not the number for you.

Can we improve the odds? The GnRH-agonist-before-transfer question

A common strategy is a short course of GnRH-agonist injections to quieten the disease and prepare the lining before a frozen embryo transfer (a β€œfreeze-all then transfer later” plan). The rationale is sound and several earlier studies reported lower miscarriage and higher live-birth rates with this approach. But the evidence is not settled. The most recent systematic review and meta-analysis (2025), which compared the fairer β€œlike-for-like” groups β€” agonist plus a hormone-prepared transfer versus a hormone-prepared transfer alone β€” found no clear advantage (live birth OR 1.19, 95% CI 0.69–2.06), and an earlier 2022 meta-analysis likewise did not confirm a benefit.

Our position reflects that honesty: for selected women with diffuse or symptomatic adenomyosis we will consider agonist preparation as part of an individualised freeze-all/FET plan β€” but we counsel clearly that it is a reasonable option, not a proven guarantee of a higher take-home-baby rate. We do not over-treat asymptomatic disease to chase a number.

How we plan around adenomyosis at Balaji Horizon

Planning is individualised and considers the whole picture, not the scan alone: confirming the diagnosis and pattern on ultrasound/MRI, the symptom burden, uterine size, whether endometriosis co-exists, your ovarian reserve and age, and your own priorities and timeline. Where indicated we favour a freeze-all with an optimised transfer rather than a rushed fresh cycle, and we set realistic expectations from the outset. If you have had repeated miscarriages, adenomyosis is one of the factors we look for and plan against. The goal is the best realistic chance of a healthy pregnancy with the least necessary intervention β€” not surgery or medication for its own sake.

More questions on adenomyosis and fertility

Does adenomyosis lower my chances with IVF?
On average it modestly lowers the chance of clinical pregnancy and live birth and raises early-miscarriage risk, but the effect is mainly seen with diffuse, symptomatic disease β€” an incidental, symptom-free finding on a scan is far less likely to change your outcome. The honest summary is: it shifts the odds a little and is worth planning around, not a reason to lose hope.
Does a course of GnRH-agonist injections before embryo transfer improve success?
It may be considered for diffuse or symptomatic adenomyosis as part of a planned frozen-transfer cycle, and some studies reported better outcomes. However, the most recent meta-analysis (2025) did not show it clearly outperforms a standard hormone-prepared frozen transfer. We discuss it as a reasonable, individualised option β€” not a guaranteed benefit β€” and avoid using it where it is unlikely to help.
I have adenomyosis and endometriosis together β€” does that affect fertility more?
Yes. Pooled data suggest that when adenomyosis co-exists with endometriosis, live-birth rates in IVF are lower than with endometriosis alone (odds ratio around 0.44). It does not mean pregnancy is out of reach β€” it means the two conditions should be assessed and planned for together, which is exactly the combined endometriosis-and-fertility approach this centre is built around.

Selected evidence

  1. Vercellini P, et al. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum Reprod. 2014;29(5):964–977. doi:10.1093/humrep/deu041
  2. Younes G, Tulandi T. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis. Fertil Steril. 2017;108(3):483–490. doi:10.1016/j.fertnstert.2017.06.025
  3. Cozzolino M, et al. The effect of uterine adenomyosis on IVF outcomes: a systematic review and meta-analysis. Reprod Sci. 2022;29(11):3177–3193. doi:10.1007/s43032-021-00818-6
  4. Wang X-L, et al. Different subtypes of ultrasound-diagnosed adenomyosis and in vitro fertilization outcomes: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2023;102(6):657–668. doi:10.1111/aogs.14580
  5. Steinmann M, et al. GnRH agonist pretreatment prior to frozen embryo transfer in women with adenomyosis: a systematic review and meta-analysis. Reprod Biomed Online. 2025;51(5):105075. doi:10.1016/j.rbmo.2025.105075

Educational information, not a substitute for individual consultation. Reviewed by Dr. Priyadatt Patel, Balaji Horizon Women’s Hospital, Ahmedabad.

Discuss your diagnosis and care options with a specialist
Evidence-based, fertility-aware endometriosis care in Ahmedabad.
Book a Consultation
β˜…β˜…β˜…β˜…β˜…5.0 Β· 282 Verified Google Reviews

Dr. Priyadatt Patel

Senior Gynecologist Β· Advanced Laparoscopic Surgeon Β· IVF and Endometriosis Programme Lead

MS OBGyn Β· Pregnancy Care Β· Advanced Gynaecological Ultrasound Β· Fertility Preservation

ESHRE / ESGE / AAGL / ASRM guideline-aligned practice. 3D Karl Storz precision technique. Fertility-preservation-first philosophy. Evidence-based decisions, honest counselling, long-term outcomes orientation.

Endometriosis
Superficial to deep infiltrating, fertility-preserving excision
IVF & Fertility
Individualised protocols, ART Level 2 lab, transparent outcomes
Advanced Laparoscopy
3D Karl Storz precision, nerve-sparing technique
Pregnancy Care
Antenatal care, high-risk pregnancy, advanced ultrasound
Balaji Horizon Women Hospital
Science City Road, Ahmedabad 380060
Mon–Sat 11:00–20:00 Β· +91 97234 31544
Balaji Women Clinic (AEC)
Naranpura, Ahmedabad
Mon–Sat 08:30–10:30 Β· +91 70460 02566
Bureau Veritas ISO 9001 UKAS accreditation 0008 β€” Balaji Horizon Women's Hospital

Internationally Accredited · State Registered

ISO 9001:2015 Quality Management System — UKAS Accredited Certification by Bureau Veritas

Certificate IND.25.899/QM/U · Valid until 02 September 2028 · Independently verify at certcheck.ukas.com

Permanently registered under Gujarat Clinical Establishments Act, 2021 · Reg. No. CEA/AHD/262/2025 · Single Speciality Hospital · 15 Beds

Operated by Balaji Women’s Clinic · Trading as Balaji Horizon Women’s Hospital

CALL BOOK ON WHATSAPP